Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 1:50 PM
Ignite Modification Date:
2025-12-24 @ 1:50 PM
NCT ID:
NCT00158795
Eligibility Criteria:
Inclusion Criteria:
* A male or female infant between, and including, 11 and 17 weeks of age at the time of the first vaccination.
Exclusion Criteria:
* Planned administration of a vaccine not foreseen by the study protocol during the period starting 30 days before the administration of the first vaccine dose and ending 30 days after the last dose.
* Chronic administration of immunosuppressants or other immune-modifying drugs from birth until administration of first dose of study vaccine.
* Use of any investigational or non-registered product (drug or vaccine) within 30 days preceding the first dose of study vaccine, or planned use during the study period.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
3 Months
Maximum Age:
4 Months
Study:
NCT00158795
Study Brief:
Protocol Section:
NCT00158795